The Doctor Is In - Biotech in July

A conversation regarding the Therapeutics market and why it is standing out from other segments of biotech and health sciences.

Other topics covered:

• Urogen (URGN) and its triple-digit performance

• What is going on with SMID stocks

• An assessment of obesity drugs and its potential impact on markets and society